News brief
On 2026-04-28, according to Xiniu Data, Sailong Biotechnology completed equity financing for an undisclosed amount. Investors were Zhangjiaganglingyi Venture Capital Partnership (Limited Partnership). The company is a developer of AI application software.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年4月28日，据烯牛数据报道，赛陇生物完成股权投资融资，金额未披露。投资方为张家港零熠创业投资合伙企业（有限合伙）。该公司为人工智能应用软件开发商。